{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:20:11Z","timestamp":1787606411253,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chroma.2026.467292","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:33:14Z","timestamp":1784853194000},"page":"467292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ion-exchange chromatography for impurity profiling of therapeutic peptides"],"prefix":"10.1016","volume":"1785","author":[{"given":"Alexandre","family":"Goyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-544X","authenticated-orcid":false,"given":"Kelly","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2026.467292_bib0001","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMcibr2409089","article-title":"Discovery of GLP-1\u2013Based drugs for the treatment of obesity","volume":"392","author":"Drucker","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2026.467292_bib0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.chroma.2026.467292_bib0003","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tips.2023.04.003","article-title":"Recent advances in the development of therapeutic peptides","volume":"44","author":"Fetse","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chroma.2026.467292_bib0005","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s11095-024-03771-6","article-title":"Impact of manufacturing process and compounding on properties and quality of follow-on GLP-1 polypeptide drugs","volume":"41","author":"Hach","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chroma.2026.467292_bib0006","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/jasms.0c00479","article-title":"Characterization of synthetic peptide therapeutics using liquid chromatography\u2013Mass spectrometry: challenges, solutions, pitfalls, and future perspectives","volume":"32","author":"Lian","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2026.467292_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116654","article-title":"Validation of a liquid chromatography-high-resolution mass spectrometry method to quantify peptide-related impurities in teriparatide","volume":"255","author":"Weisz","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2026.467292_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/acs.oprd.4c00386","article-title":"Therapeutic peptides control strategy: perspective on current industry practices","volume":"29","author":"Pack","year":"2025","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.chroma.2026.467292_bib0009","first-page":"38","article-title":"Control Strategies for synthetic therapeutic peptide APIs - part I: analytical consideration","author":"Swietlow","year":"2014","journal-title":"Pharm Technol"},{"key":"10.1016\/j.chroma.2026.467292_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2019.05.037","article-title":"Investigation into reversed phase chromatography peptide separation systems part II: an evaluation of the robustness of a protocol for column characterisation","volume":"1603","author":"Field","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461093","article-title":"Investigation into reversed phase chromatography peptide separation systems part III: establishing a column characterisation database","volume":"1622","author":"Field","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chroma.2019.05.038","article-title":"Investigation into reversed phase chromatography peptide separation systems part I: development of a protocol for column characterisation","volume":"1603","author":"Field","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.461986","article-title":"Investigation into reversed-phase chromatography peptide separation systems part IV: characterisation of mobile phase selectivity differences","volume":"1641","author":"Field","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.462888","article-title":"Investigation into reversed-phase chromatography peptide separation systems part V: establishment of a screening strategy for development of methods for assessment of pharmaceutical peptides\u2019 purity","volume":"1668","author":"Cheung","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.463874","article-title":"A strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part I: selection of columns and mobile phases","volume":"1693","author":"Petersson","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11095-020-02817-9","article-title":"Influence of production process and scale on quality of polypeptide drugs: a case study on GLP-1 analogs","volume":"37","author":"Staby","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chroma.2026.467292_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462568","article-title":"Ultra-short ion-exchange columns for fast charge variants analysis of therapeutic proteins","volume":"1657","author":"Navarro-Huerta","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0018","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9258(18)86000-8","article-title":"A buffer solution for colorimetric comparison","volume":"49","author":"McIlvaine","year":"1921","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2026.467292_bib0019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chroma.2007.11.111","article-title":"Selection of pH-related parameters in ion-exchange chromatography using pH-gradient operations","volume":"1194","author":"Ahamed","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0020","unstructured":"B. Wagner, R. Alvarez Sanchez, K. Box, J. Comer, J. Mole, Measuring the isoelectric point of peptides by potentiometric titration, in: n.d. https:\/\/cdn.prod.website-files.com\/686d5b055e60c6e6b5284d5c\/686d5b055e60c6e6b5285658_R6225-Isoelectric-point-of-peptides.pdf (accessed July 8, 2026)."},{"key":"10.1016\/j.chroma.2026.467292_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acs.bioconjchem.4c00484","article-title":"Effect of lipidation on the structure, oligomerization, and aggregation of glucagon-like peptide 1","volume":"36","author":"P\u0159\u00e1da Brichtov\u00e1","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chroma.2026.467292_bib0022","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1021\/acs.analchem.4c02941","article-title":"Unified and versatile multiplex platform for expedited method development and comprehensive characterization of therapeutic peptides","volume":"96","author":"Goyon","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467292_bib0023","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0003-2670(97)00322-X","article-title":"Size-exclusion high-performance liquid chromatography of peptides: a review","volume":"352","author":"Irvine","year":"1997","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2026.467292_bib0024","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1021\/acsami.8b19669","article-title":"Sustained release of exendin 4 using injectable and ionic-nano-complex forming polymer hydrogel system for long-term treatment of type 2 diabetes mellitus","volume":"11","author":"Seo","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.chroma.2026.467292_bib0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41598-018-19170-y","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2026.467292_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejpb.2020.07.003","article-title":"Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-l-octaarginine","volume":"154","author":"Tomono","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chroma.2026.467292_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2012.04.022","article-title":"Minimizing acylation of peptides in PLGA microspheres","volume":"162","author":"Zhang","year":"2012","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.chroma.2026.467292_bib0028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acs.jcim.2c01261","article-title":"pIChemiSt - free tool for the calculation of isoelectric points of modified peptides","volume":"63","author":"Frolov","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.chroma.2026.467292_bib0029","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/acs.jcim.7b00030","article-title":"pICalculax: improved prediction of isoelectric point for modified peptides","volume":"57","author":"Bjerrum","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.chroma.2026.467292_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122379","article-title":"Development of an innovative salt-mediated pH gradient cation exchange chromatography method for the characterization of therapeutic antibodies","volume":"1160","author":"Goyon","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2026.467292_bib0031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9673(01)81643-5","article-title":"Separation of peptides by strong cation-exchange high-performance liquid chromatography","volume":"327","author":"Mant","year":"1985","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9673(01)93883-X","article-title":"Strong cation-exchange high-performance liquid chromatography of peptides: effect of non-specific hydrophobic interactions and linearization of peptide retention behaviour","volume":"476","author":"Lorne Burke","year":"1989","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467292_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316623","article-title":"Enhancing selectivity of protein biopharmaceuticals in ion exchange chromatography through addition of organic modifiers","volume":"24","author":"Duivelshof","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2026.467292_bib0034","author":"Zhenyu"},{"key":"10.1016\/j.chroma.2026.467292_bib0035","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/pharmaceutics13081263","article-title":"The effects of pH and excipients on exenatide stability in solution","volume":"13","author":"Benet","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chroma.2026.467292_bib0036","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326006205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326006205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:28:02Z","timestamp":1787603282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967326006205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0021967326006205"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467292","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ion-exchange chromatography for impurity profiling of therapeutic peptides","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"467292"}}